Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus
暂无分享,去创建一个
I. Shimomura | H. Kaneto | H. Watada | Y. Umayahara | M. Gosho | T. Shiraiwa | N. Katakami | T. Mita | H. Yoshii | T. Osonoi | K. Kosugi | N. Kuribayashi
[1] Gang Liu,et al. Clinical analysis of 215 consecutive cases with fever of unknown origin , 2018, Medicine.
[2] C. Fidler,et al. Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes , 2016, Diabetes Therapy.
[3] I. Shimomura,et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) , 2016, Diabetes Care.
[4] L. Stojanovska,et al. Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study , 2015, Vascular health and risk management.
[5] J. G. García Santos,et al. Carotid intima-media thickness and hemodynamic parameters: reproducibility of manual measurements with Doppler ultrasound. , 2015, Medical ultrasonography.
[6] H. Itoh,et al. Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial , 2015, PloS one.
[7] K. Khunti,et al. Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study , 2014, Diabetes Care.
[8] R. Kawamori,et al. Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery. , 2014, Endocrinology.
[9] I. Shimomura,et al. Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE) , 2014, Diabetology & Metabolic Syndrome.
[10] E. Ortega,et al. Vitamin C Further Improves the Protective Effect of Glucagon-Like Peptide-1 on Acute Hypoglycemia-Induced Oxidative Stress, Inflammation, and Endothelial Dysfunction in Type 1 Diabetes , 2013, Diabetes Care.
[11] Young Seol Kim,et al. Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes , 2013, Diabetes & metabolism journal.
[12] T. Kondo,et al. Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. , 2013, Endocrine journal.
[13] A. Goto,et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis , 2013, BMJ.
[14] M. Namba,et al. Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus. , 2013, Endocrine journal.
[15] W. L. Jin,et al. Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta , 2011, Diabetologia.
[16] R. Casamitjana,et al. Repeated Episodes of Hypoglycemia as a Potential Aggravating Factor for Preclinical Atherosclerosis in Subjects With Type 1 Diabetes , 2010, Diabetes Care.
[17] Mark Woodward,et al. Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.
[18] A. Ertl,et al. Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals , 2010, Diabetes Care.
[19] D. Newby,et al. Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation , 2010, Diabetes Care.
[20] Michael E. Miller,et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.
[21] J. Rosenstock,et al. Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia , 2009, Diabetes, obesity & metabolism.
[22] J. N. Fisher,et al. Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.
[23] A. Ertl,et al. Effects of Intensive Therapy and Antecedent Hypoglycemia on Counterregulatory Responses to Hypoglycemia in Type 2 Diabetes , 2009, Diabetes.
[24] Grant D. Huang,et al. Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.
[25] S. Dejager,et al. Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes , 2007, Diabetologia.
[26] G. Thomson,et al. Insulin-induced hypoglycemia induces a rise in C-reactive protein. , 2000, Diabetes care.
[27] B. Frier,et al. Leucocyte Mobilization and Release of Neutrophil Elastase Following Acute Insulin‐induced Hypoglycaemia in Normal Humans , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[28] E. B. French,et al. Peripheral blood cell changes in response to acute hypoglycaemia in man , 1983, European journal of clinical investigation.
[29] S. Madsbad,et al. Changes in Platelet Function, Blood Coagulation and Fibrinolysis During Insulin-Induced Hypoglycaemia in Juvenile Diabetics and Normal Subjects , 1982, Thrombosis and Haemostasis.
[30] M. Sata,et al. Inflammatory Biomarkers and Atherosclerosis. , 2016, International heart journal.
[31] S. Schinner. Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .
[32] S. Schinner. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .
[33] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[34] J. Smith,et al. Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade. , 1992, Hormone and metabolic research. Supplement series.